Evidence-Based Complementary and Alternative Medicine

Research Article

Untargeted Metabolomics Reveals Intervention Effects of Total Turmeric Extract in a Rat Model of Nonalcoholic Fatty Liver Disease

Table 2

List and change trends of differential metabolites.


Number	RT (min)	Mass (m/z)	Metabolites	Formula	Model trend	HD-TE trend

1	0.95	206.0419	2-C-Methyl-D-erythritol 4-phosphate	C₅H₁₃O₇P		^#
2	5.12	229.0371	5-Phosphoribosylamine	C₅H₁₂NO₇P	—	^##
3	14.46	360.1873	Cortisone	C₂₀H₂₈O₅		^##
4	15.24	284.1776	Androsta-1,4-diene-3,17-dione	C₁₉H₂₄O₂		^##
5	15.95	476.2441	all-trans-Retinoyl-beta-glucuronide	C₂₆H₃₆O₈		^##
6	16.17	535.3668	1-Acyl-sn-glycero-3-phosphoethanolamine (LysoPE)	C₂₇H₅₄NO₇P
7	16.34	434.2463	1-Acyl-sn-glycerol-3-phosphate LPA(18:2(9Z,12Z)/0:0)	C₂₀H₃₉O₇P		^##
8	17.19	757.5842	Phosphatidylethanolamine PE(15:0/22:2(13Z,16Z))	C₄₂H₈₀NO₈P		^#
9	17.20	164.1220	2,4,6-Undecatrienal	C₁₁H₁₆O		^##
10	17.42	368.2563	Cortol	C₂₀H₃₆O₅		^##
11	17.45	332.2351	21-Hydroxypregnenolone	C₂₀H₃₂O₃		^##
12	17.46	366.2473	Cortolone	C₂₀H₃₄O₅		^##
13	18.49	408.3038	4Z,7Z,10Z,13Z,16Z,19Z,22Z,25Z-Octacosaoctaenoic acid (fatty acid)	C₂₈H₄₀O₂		^##
14	19.31	588.2944	D-Urobilin	C₃₃H₄₀N₄O₆		^##
15	20.48	424.3008	1-Alkyl-sn-glycero-3-phosphate (1-octadecyl lysophosphatidic acid)	C₂₀H₄₅O₆P		^##
16	22.63	428.3684	Cholesteryl ester (CE(12:0))	C₂₉H₄₈O₂		^##
17	22.74	686.4913	1,2-Diacyl-sn-glycerol	C₄₅H₆₆O₅		^#
18	22.76	720.4941	Phosphatidylglycerol [PG(14:0/18:1(9Z))]	C₃₈H₇₃O₁₀P		^##
19	22.93	727.4572	Phosphatidyl-L-serine PS(14:1(9Z)/18:3(9Z,12Z,15Z))	C₃₈H₆₆NO₁₀P		^##
20	23.04	660.5034	1,2-Diacyl-sn-glycerol 3-phosphate PA(P-20:0/14:0)	C₃₇H₇₃O₇P		^##

Compared to the normal group. Compared to the model group. The significantly changed biomarkers were flagged with () downregulated, () upregulated, and (—) invalid data; P < 0.05, P < 0.01.